Georgia's Online Cancer Information Center

Wayne and Lisa Merritt: From devastation to a miracle

Wayne and Lisa Merritt

When Wayne Merritt was diagnosed with stage IV pancreatic cancer, it had been less than a year after his wife, Lisa had recovered from treatment for breast cancer. It was devastating to hear the words, “inoperable” and “three to six months to live.” His chances at survival seemed even less hopeful knowing that he did not want to go through chemotherapy after having just experienced it with Lisa.

So, Wayne and Lisa set out looking for alternatives. Some came with hefty price tags beyond what insurance would cover, required out of state travel, or turned out to be a “repackaging” of conventional therapy. One of the worst results was that unbeknownst to them, Wayne started chemotherapy during an alternative treatment. When they decided not to carry on that treatment, he could no longer participate in any first round clinical trials.

After this huge setback and waning hope, the couple found an oncologist who they “believe is treating the whole person and not just the cancer,” said Lisa. They brought Wayne’s treatment plan back to their home community of Rome and the Harbin Clinic and began the regime of chemotherapy and a strict diet of unprocessed foods and no sugars. They changed their lifestyle. And they prayed continually.

June 2012 was Wayne’s last chemo treatment. And there’s been no change in the tumor found in his pancreas. “Our doctors call me a miracle,” said Wayne. But more than anything, the couple attributes his survival to determination, strong faith, and the diet and the lifestyle changes they made together.

Wayne and Lisa celebrated their 25-year wedding anniversary in 2013.

Back to Survivors' Voices


Looking Across Disciplines to Share the Breadth of Innovation in Cancer Care

On July 25, 2023, The American Journal of Managed Care® brought its Institute for Value-Based Medicine (IVBM) series to Atlanta, Georgia, where nnovation was on the agenda.


DNA sequencing can lead to longer, better lives for cancer patients. But why do so few get it?

Guidelines now call for everyone diagnosed with advanced lung and colon cancer to get their tumor genetically sequenced, and increasingly, patients with earlier stage disease, as well.


Georgia CORE releases report from Disparities in Cancer Clinical Trials Summit

On Sept. 30, Georgia's cancer experts shared advice and experiences with oncology providers, patient navigators and research managers - all to provide new ways to diversify participation in clinical trials. In February 2023, Georgia CORE issued a report with a recap and actions steps. Download the report >>


Georgia CORE


Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.